Markels John
- SEC CIK
- 0001803424
No open-market purchases or sales filed in the past year.
Current role at each company
- PCVX Vaxcyte, Inc.Directoras of Jul 16, 2026
- ARCT Arcturus Therapeutics Holdings Inc.Directoras of Jun 15, 2026
- SGMOQ Sangamo Therapeutics, IncDirectoras of Jun 16, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Markels John as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
SGMOQ Sangamo Therapeutics, Inc
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 6, 2022 (view filing) | Jun 3 | 3 days | Markels JohnDirector | PPurchase | +6.78K | $3.69 | +$25.0K | +26.4%32.5K after |